At Emergent, we develop, manufacture, and deliver protections against public health threats. For more than two decades, we’ve been at work defending people from things we hope will never happen — so that we’re prepared, just in case they ever do.
Having over-the-counter (OTC) naloxone gives us the opportunity to make it mainstream where it hasn’t been before. The teamwork, hard work, and collaboration that has brought us to this point is essential to me. We have been able to bring this product to OTC because of accessibility, barrier removal, and the opportunity for everyone to have access.
The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…
Physician burnout has become a defining challenge in healthcare, with research showing that a substantial portion of clinicians—anywhere from roughly a quarter to over half—experience emotional exhaustion, driven more by systemic pressures like administrative burden and reduced autonomy than by individual resilience alone. As healthcare systems face growing staffing shortages and rising patient demand, the…
Healthcare teams today are feeling the pressure to move beyond last-minute compliance and instead build processes that work consistently every day. That shift is especially clear in sterile processing departments (SPDs), where the Joint Commission 360 model is redefining what “survey readiness” really means. With patient safety directly tied to instrument quality—and studies consistently…